Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
22 studies found for:    Open Studies | "Leishmaniasis"
Show Display Options
Rank Status Study
1 Not yet recruiting Predicting Visceral Leishmaniasis in HIV Infected Patients
Condition: Leishmaniasis, Visceral
Intervention: Other: No intervention
2 Recruiting The Association of Miltefosine and Pentoxifylline to Treat Mucosal Leishmaniasis: A Clinical Trial in Brazil
Condition: Leishmaniasis
Interventions: Drug: Meglumine antimoniate;   Drug: Miltefosine;   Drug: Pentoxifylline
3 Recruiting Dedicated QT Study in Bolivian Patients Taking Impavido® (Miltefosine) for Mucocutaneous Leishmaniasis
Condition: Mucocutaneous Leishmaniasis
Intervention: Drug: Miltefosine
4 Recruiting Spermiogram Assessment in Bolivian Patients Taking Impavido® (Miltefosine) for Mucocutaneous Leishmaniasis
Condition: Mucocutaneous Leishmaniasis
Intervention: Drug: Miltefosine
5 Not yet recruiting Single Dose Liposomal Amphotericin B for Visceral Leishmaniasis
Condition: Visceral Leishmaniasis
Intervention: Drug: AMBISOME
6 Recruiting Treatment of Leishmaniasis With Impavido® (Miltefosine): Higher-Weight Patient Registry
Condition: Leishmaniasis
Intervention: Drug: Miltefosine
7 Not yet recruiting Miltefosine and GM-CSF in Cutaneous Leishmaniasis
Condition: Cutaneous Leishmaniasis
Interventions: Drug: Sbv;   Drug: Miltefosine plus placebo;   Drug: Miltefosine plus GM-CSF
8 Recruiting Treatment of Leishmaniasis With Impavido® (Miltefosine): Pregnancy Registry
Condition: Leishmaniasis or Other Uses of Miltefosine
Intervention: Drug: Miltefosine
9 Not yet recruiting Topical Liposomal Amphotericin B Gel Treatment for Cutaneous Leishmaniasis
Condition: Leishmaniasis
Intervention: Drug: Topical Amphotericin-B 0.4% liposomal gel
10 Recruiting Low Antimonial Dosage in American Mucosal Leishmaniasis
Conditions: Mucosal Leishmaniasis;   Mucocutaneous Leishmaniasis
Intervention: Drug: Meglumine antimoniate
11 Available Compassionate Use of Sodium Stibogluconate (Pentostam) for Cutaneous and Mucocutaneous New World Leishmaniasis
Conditions: Leishmaniasis, Cutaneous;   Leishmaniasis, Mucocutaneous
Intervention: Drug: sodium stibogluconate (Pentostam)
12 Available Paromomycin for Individuals With Uncomplicated Cutaneous Leishmaniasis
Condition: Leishmaniasis, Cutaneous
Intervention: Drug: Paromomycin
13 Available Pilot Study Using a Heat Pack to Treat Cutaneous Leishmaniasis
Condition: Cutaneous Leishmaniasis
Intervention: Device: Heat pack conduction-heat therapy
14 Not yet recruiting Miltefosine/Paromomycin Phase III Trial for Treatment of Primary Visceral Leishmaniasis (VL) Patients in Eastern Africa
Condition: Visceral Leishmaniasis
Interventions: Drug: Miltefosine;   Drug: Paromomycin;   Drug: Sodium stibogluconate
15 Recruiting Thermotherapy + a Short Course of Miltefosine for the Treatment of Uncomplicated Cutaneous Leishmaniasis in the New World¨
Condition: Cutaneous Leishmaniasis
Intervention: Drug: Miltefosine
16 Recruiting Asymptomatic Leishmania Infection in HIV Patients
Condition: Visceral Leishmaniasis
Intervention:
17 Not yet recruiting Phase 2 Trial to Evaluate 18-Methoxycoronaridine Efficacy, Safety and Tolerability in Cutaneous Leishmaniasis Patients
Conditions: Leishmaniasis; American, Cutaneous;   Drug Side Effect
Interventions: Drug: 18-Methoxycoronaridine;   Drug: Glucantime
18 Recruiting Miltefosine for Children With PKDL
Condition: Post Kala Azar Dermal Leishmaniasis
Intervention: Drug: Miltefosine
19 Recruiting Accuracy of a Rapid Diagnostic Test for Cutaneous Leishmaniasis in Morocco
Conditions: Cutaneous Leishmaniasis;   Skin Diseases, Parasitic;   Neglected Diseases
Intervention:
20 Recruiting Diagnosis and Treatment of Leishmanial Infections
Condition: Leishmaniasis
Intervention:

   Previous Page Studies Shown (1-20) Next Page (21-22) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.